Federal Circuit Agrees: DNA Testing Patent Not Shown To Be Obvious
WASHINGTON, D.C. — The U.S. Patent Trial and Appeal Board (PTAB) did not err when it held that a biopharmaceutical company failed to show that a patent held by another company...To view the full article, register now.
Already a subscriber? Click here to view full article